Michal Einat is an author at Tel Aviv University specializing in molecular pharmacology, drug discovery, and drug development.
Top concepts
MedicineOncologyHematologyImmunologyPharmacologyDrug DiscoveryPharmacotherapyDrug DevelopmentMedicinal ChemistryMolecular Pharmacology
Publications per year
1995–1995
2
2
Potent antileukemic activity of the novel agents norsegoline and dibezine.
Michal Einat, Arnon Nagler, Michael Lishner et al. · PubMed · 1995 · 11 citations
Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19
Rows per page
1–2 of 2